In summary, increased TEM8 levels have been shown to lead to decreased overall survival in lung cancer [18,24], angiosarcoma [48], colorectal cancer [47], gastric cancer [23], prostate cancer [45], and ovarian cancer [15]. Here, ANTXR1 is linked to ovarian cancer.